Vaginally applied microbicide products offer a female-controlled strategy for preventing sexual transmission of HIV. Microbicide transport processes are central to their functioning, and there is a clear need for a better understanding of them. To contribute to that end, we developed an assay to analyze mass transport rates of microbicide molecules within the epithelial and stromal layers of polarized vaginal mucosal tissue during contact with a gel vehicle. The assay utilizes a new diffusion chamber mounted in a custom instrument that combines confocal Raman spectroscopy and optical coherence tomography. This measures depth-resolved microbicide concentration distributions within epithelium and stroma. Data for a tenofovir gel were fitted with a compartmental diffusion model to obtain fundamental transport properties: the molecular diffusion and partition coefficients in different compartments. Diffusion coefficients in epithelium and stroma were computed to be 6.10 ± 2.12 x 10−8 and 4.52 ± 1.86 x 10−7 cm2/sec, respectively. The partition coefficients between epithelium and gel and between stroma and epithelium were found to be 0.53 ± 0.15 and 1.17 ± 0.16, respectively. These drug transport parameters are salient in governing the drug delivery performance of different drug and gel vehicle systems. They can be used to contrast drugs and vehicles during product design, development and screening. They are critical inputs to deterministic transport models that predict the gels’ pharmacokinetic performance, which can guide improved design of products and optimization of their dosing regimens.
Breathalyzer is a common approach to measuring blood alcohol concentration (BAC) levels of individuals suspected of drunk driving. Nevertheless, this device is relatively high-cost, inconvenient for people with limited breathing capacity, and risky for COVID-19 exposure. Here, we designed and developed a smart wristband integrating a real-time noninvasive sweat alcohol metal oxide (MOX) gas sensor with a Drunk Mate, an Internet of Thing (IoT)-based alarming system. A MOX sensor acquired transdermal alcohol concentration (TAC) which was converted to BAC and sent via the IoT network to the Blynk application platform on a smartphone, triggering alarming messages on LINE Notify. A user would receive an immediate alarming message when his BAC level reached an illegal alcohol concentration limit (BAC 50 mg%; TAC 0.70 mg/mL). The sensor readings showed a high linear correlation with TAC (R2 = 0.9815; limit of detection = 0.045 mg/mL) in the range of 0.10–1.05 mg/mL alcohol concentration in artificial sweat, achieving an accuracy of 94.66%. The sensor readings of ethanol in water were not statistically significantly different (p > 0.05) from the measurements in artificial sweat and other sweat-related solutions, suggesting that the device responded specifically to ethanol and was not affected by other electrolytes in the artificial sweat. Moreover, the device could continuously monitor TAC levels simulated in real-time in an artificial sweat testing system. With the integration of an IoT-based alarming system, the smart wristband developed from a commercial gas sensor presented here offers a promising low-cost MOX gas sensor monitoring technology for noninvasive and real-time sweat alcohol measurement and monitoring.
Cholangiocarcinoma (CCA) is highly prevalent in the northeastern region of Thailand. Current diagnostic methods for CCA are often expensive, time-consuming, and require medical professionals. Thus, there is a need for a simple and low-cost CCA screening method. This work developed a rapid label-free technique by Raman spectroscopy combined with the multivariate statistical methods of principal component analysis and linear discriminant analysis (PCA-LDA), aiming to analyze and classify between CCA (n = 30) and healthy (n = 30) serum specimens. The model’s classification performance was validated using k-fold cross validation (k = 5). Serum levels of cholesterol (548, 700 cm-1), tryptophan (878 cm-1), and amide III (1248,1265 cm-1) were found to be statistically significantly higher in the CCA patients, whereas serum beta-carotene (1158, 1524 cm-1) levels were significantly lower. The peak heights of these identified Raman marker bands were input into an LDA model, achieving a cross-validated diagnostic sensitivity and specificity of 71.33% and 90.00% in distinguishing the CCA from healthy specimens. The PCA-LDA technique provided a higher cross-validated sensitivity and specificity of 86.67% and 96.67%. To conclude, this work demonstrated the feasibility of using Raman spectroscopy combined with PCA-LDA as a helpful tool for cholangiocarcinoma serum-based screening.
1 June 2025 in Journal of the Electrochemical Society
This work presents a palm-sized, cost-effective biosensing device that integrates an enzymatic paper biosensor with an Internet of Things (IoT)-enabled smartphone alert system for fluid-based alcohol detection. The device consists of a paper-based sensing platform, a potentiostat-free data acquisition system using commercially available electronic modules, and an IoT-based wireless alert that notifies the user via smartphone when their blood alcohol concentration (BAC) exceeds the legal limit. The biosensor utilizes alcohol oxidase (AOx) as the catalytic enzyme, immobilized on filter paper and stabilized by bovine serum albumin (BSA). Both electrodes are fabricated from widely accessible materials: aluminum tape as the cathode and graphene–nail polish ink as the anode. Housed in a compact, 3D-printed enclosure (3 × 5 × 5 cm3), the device achieved high electron transfer efficiency with an internal resistance of 10 kΩ. It exhibited a strong linear correlation (R2 = 0.9798) across a range of 14.02–88.45 mg dl−1 (sweat-calculated BAC) and 20.70–119.14 mg dl−1 (saliva-calculated BAC), with detection limits of 7.82 mg dl−1 (sweat) and 12.51 mg dl−1 (saliva). The device demonstrates sensitivity across BAC levels from the mild impairment threshold to above the legal limit, with high alcohol specificity. It provides a portable, cost-effective solution for fluid-based alcohol monitoring in low-resource settings.
This study presents a low-cost, paper-based electrochemical biosensor for noninvasive ethanol detection in human saliva. The device integrates alcohol oxidase (AOx) on a foldable paper substrate with carbon electrodes and real-time, smartphone-compatible IoT monitoring. The biosensor exhibited a strong linear response to ethanol-spiked human saliva over the range of 0–144 mg/dL (R² = 0.926), encompassing both physiologically and legally relevant levels, with a detection limit of 14.9 mg/dL. It demonstrated high selectivity across both artificial and human saliva and maintained stable performance for up to 3–5 weeks at 4°C. The biosensor showed a strong correlation with GC-FID (R² = 0.998; relative error ±5%), confirming its quantitative accuracy for salivary alcohol analysis. This portable and effective biosensing platform offers a compact and accurate tool for salivary alcohol quantification, demonstrating significant potential for roadside screening and personal health monitoring.